On Thursday May, 2, the U.S. Nuclear Regulatory Commission (NRC) published a notice in the Federal Register announcing a 30-day public comment period and two public meetings on the NRC staff’s draft approaches regarding training and experience requirements for administration of radiopharmaceuticals requiring a written directive.

This is one of several information-gathering activities that will help the agency decide whether to open this up to rule-making. The society's expert work group will address the open notice and questions included in the notice. Although SNMMI will be submitting comments, we encourage all members to submit their own comments. The comment period will end on June 3, 2019.

The NRC is also accepting oral comments during two public meetings, scheduled for May 14 and May 23. The May 14 meeting is open to members of the public for in-person attendance at the NRC’s headquarters in Rockville, MD, and both meetings will be accessible for remote participation by moderated bridge line and webinar. NRC’s public meeting Web site will be updated with meeting details at least 10 days before the meetings.
SNMMI previously submitted comments to the NRC on training and experience requirements for authorized users for medical uses under Subpart E, “Unsealed Byproduct Material—Written Directive Required.” SNMMI comments highlight the importance of patient and public safety, while ensuring access to quality care.

Molecular Imaging Homepage